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a b s t r a c t
Catechol-O-methyltransferase (COMT, EC 2.1.1.6) plays a crucial role in dopamine metabolism which has
intimately linked this enzyme to some neurodegenerative diseases, such as Parkinson’s disease. In recent
years, in the attempt of developing new therapeutic strategies for Parkinson’s disease, there has been a
growing interest in the search for effectiveCOMT inhibitors. In order todo so, large amounts of COMT in an
active form are needed, and the best way to achieve this is by up-scaling its production through biotech-
nological processes. In this work, a fed-batch process for the biosynthesis of the soluble isoform of COMT
in Escherichia coli is proposed. This ﬁnal process was selected through the evaluation of the effect of dif-
ferent dissolved oxygen concentrations, carbon and nitrogen source concentrations and feeding proﬁles
on enzymatic production and cell viability, while controlling various parameters (pH, temperature, start-
ing time of the feeding and induction phases and carbon source concentration) during the process. After
several batch and fed-batch experiments, a ﬁnal speciﬁcCOMTactivity of 442.34nmol/h/mgwith approx-
imately 80% of viable cells at the end of the fermentation were achieved. Overall, the results described
herein provide a great improvement on hSCOMT production in recombinant bacteria and provide a new
and viable option for the use of a fed-batch fermentation with a constant feeding proﬁle to the large scale
production of this enzyme.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND. Introduction
Catechol-O-methyltransferase (COMT, E.C. 2.1.1.6) is a methyl-
ransferase enzyme that catalyses the transfer of the methyl group
romS-adenosyl-l-methionine (SAM) tooneof thehydroxyl groups
f the catechol substrate (including catecholamine neurotrans-
itters and catechol estrogens) in the presence of Mg2+ [1]. This
ethylation reaction is a sequentially ordered mechanism, with
AMbeing the ﬁrst to bind to the enzyme, followed by theMg2+ ion
nd ﬁnally the substrate [1]. The enzyme exists as two isoforms: a
oluble, cytosolic protein (SCOMT) and amembrane-bound protein
MBCOMT) [2], both coded by the same gene (located in chromo-
ome 22) from two promoters. The general function of COMT is
he elimination of biologically active or toxic catechols and other
etabolites, while playing a particularly important role in the
∗ Corresponding author at: Health Sciences Research Centre (CICS), Faculty of
ealth Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506
ovilhã, Portugal. Tel.: +351 275 329 069; fax: +351 275 329 099.
E-mail addresses: lpassarinha@fcsaude.ubi.pt, lapp@ubi.pt (L.A. Passarinha).
ttp://dx.doi.org/10.1016/j.btre.2014.05.005
215-017X/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
metabolism of catecholamines, especially in the breakdown of the
neurotransmitter dopamine [3].
Over the last decades, the lack of dopamine has been linked to
Parkinson’s disease (PD) [4], and so, levodopa and dopamine ago-
nists are currently the drugs of choice for PD when a signiﬁcant
symptomatic effect needs to be achieved [5]. However, the use of
COMT inhibitors plus levodopa is more effective at reducing PD
symptoms when compared to the use of levodopa alone [6]. In the
present, only two COMT inhibitors are currently available, namely
tolcapone, which use is restricted; and entacapone, a safer but less
efﬁcient compound [7]. In order to develop new COMT inhibitors,
a high quantity of enzymatically active COMT is needed, either for
crystallization studies based on structural-based inhibitors inter-
actions [8], or to perform in vitro experiments required for the
development of a new drug formulation.
The best strategy to obtain considerable amounts of human
proteins is by applying recombinant technology. In the case of
recombinant human SCOMT (hSCOMT), it has been produced via
different expression systems, such as transfected mammalian cells
[9], insect cells (via mammalian and baculovirus vectors) [10],
plant cells (via a potyvirus) [11] and prokaryotic cells, such as
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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scherichia coli. E. coli is a Gram-negative bacterium and is the most
ommonly used organism for heterologous human protein biosyn-
hesis [12–16], allowing theestablishmentof large scaleproduction
ystems due to its ability to quickly reach high cell densities in
nexpensive media.
For routine protein expression, E. coli B and K strains, along with
heir derivatives, are themost frequently used, with BL21 being the
ost suitable strain for protein production due to the lack of two
peciﬁc proteases (lon and ompT), thus avoiding heterologous pro-
ein degradation. One particular BL21 derivative strain, E. coli BL21
DE3), has been used to successfully express thousands of homol-
gous and heterologous soluble proteins to high levels [16,17],
ncluding COMT [18–20]. Apart from the optimization of growth
onditions, to achieve high quantities of recombinant protein, a
arge-scale culture processes have to be applied, mostly based on
ed-batch mode cultures [14,21,22].
A fed-batch culture is generally started with an inoculum grow-
ng at the maximum speciﬁc growth rate that can be sustained
sing the nutrients initially present in the bioreactor, followed by
he imposition of a speciﬁc regime of nutrient feed until fermen-
ation is complete [14]. These methods are based on mathematical
odels that describe growth patterns and the expected demand
or nutrients [22]. Regarding the pattern of nutrient addition, three
ain types of pre-determined feeding proﬁles can be considered:
onstant, exponential and stepwise feeds [14]. Another feeding
pproach that canbeused is basedon thedirect or indirect feedback
ontrol systems for the controlled addition of nutrients. Indirect
ontrol is based on online monitoring of parameters such as pH,
issolved oxygen, CO2 evolution rate and cell concentration. Direct
eedback is based on monitoring the concentration of the major
arbon substrate [14,22].
In this work, a fed-batch bioprocess was developed, via an
p-scaling of hSCOMT production. Initially, several batch fermen-
ations were carried out, in order to establish the ideal culture
onditions, for instance batch phase and bioreactor operation for
he fed-batch fermentations. After this stage, several fed-batch fer-
entations with different feeding proﬁles were tested in order
o maximize biomass production and to improve protein activity
evels, without compromising cell viability.
. Materials and methods
.1. Chemicals
Ultrapure reagent-grade water was obtained from a Mili-Q
ystem (Millipore/Waters). Carbenicillin disodium salt, calcium
hloride dihydrate, magnesium sulfate heptahydrate, lysozyme,
obalt(II) chloride hexahydrate, dithiothreitol (DTT), SAM chloride
alt, DNase, epinephrine (bitartrate salt), disodium ethylene-
iamine tetraacetic acid (EDTA), sodium octyl sulfate (OSA),
ovine serum albumin (BSA), LB-Agar, IPTG, tryptone, glycerol
nd propidium iodide (PI) were obtained from Sigma Chemical
o. (St. Louis, MO, USA). Potassium chloride, sodium chlo-
ide, boric acid were supplied by Fluka (Buchs, Switzerland).
odium phosphate dibasic and potassium dihydrogen phosphate
onobasic were obtained from Panreac (Barcelona, Spain). Bis-
1,3-dibutylbarbituric acid)trimethine oxonol (BOX) was obtained
rom Molecular Probes®, Invitrogen, part of Life Technologies
Carlsbad, CA, USA). All other chemicals were of analytical grade
nd used without further puriﬁcation.
.2. Methods.2.1. Expression vector and bacterial strain
The Champion pET101Directional TOPO expression kit (Invitro-
en Corporation, Carlsbad, CA, USA) was used for the expressionlogy Reports 3 (2014) 34–41 35
of hSCOMT on E. coli BL21(DE3) strain kindly provided by Bial
(Departamento de Investigac¸ão e Desenvolvimento, São Mamede
do Coronado, Portugal).
2.2.2. Escherichia coli pre-cultivation, batch and fed-batch
fermentations
In this study, except for tryptone and glycerol concentrations,
all media components for the semi-deﬁned medium were kept
constant (5.5 g/L Na2HPO4, 0.5 g/L NaCl, 1.64 g/L citric acid mono-
hydrate, 2 g/L potassium citrate, 1.21 g/L MgSO2·7H2O, 50g/mL
carbenicillin and 1.5mL/L trace elements solution) for the pre-
cultivations, batch, and batch phase of fed-batch experiments. The
trace elements solution consisted of 27g/L FeCl3·6H2O, 2 g/L ZnCl2,
2 g/L CoCl2·6H2O, 2 g/L Na2MoO4·2H2O, 1 g/L CaCl2·2H2O, 1.2 g/L
CuSO4 and 0.5 g/L H3BO4, prepared in 1.2M HCl. LB agar plates
supplemented with 50g/mL carbenicillin were inoculated from
a cell bank aliquot and grown overnight at 37 ◦C. Afterwards, a
pre-cultivation was performed inoculating a single colony into a
500mL shake ﬂask containing 125mL of semi-deﬁned medium,
and grown at 37 ◦C and 250 rpm until an optical density at 600nm
(OD600) of approximately 2.6 was reached. Batch and fed-batch
processes were carried out in 750mL bench-top parallel mini-
bioreactors (Infors HT, Switzerland) with 250mL of semi-deﬁned
medium. In our research group, three physical culture conditions
for the production of hSCOMT in shake ﬂasks were already opti-
mized [20], namely temperature (40 ◦C), pH (6.5) and stirring rate
(351 rpm) and this was the starting point for the strategy described
in the present work. So, the bioreactors were inoculated from the
pre-cultivation to obtain a starting OD600 of approximately 0.2.
Temperature and pH were kept constant throughout the batch and
fed-batch phases at 40 ◦C and 6.5, as previously optimized,with the
pH value controlled by the automatic addition of 0.75M H2SO4 and
0.75M NaOH through two peristaltic pumps. The dissolved oxygen
percentage (pO2) was controlled by a two-level cascade of stirring
(between 250 and 900 rpm) and air ﬂow (between 0.2 and 2vvm).
In general, the feeds consisted of different concentrations of
tryptone and glycerol dissolved in deionized water and their addi-
tion was maintained by automated peristaltic pumps controlled by
IRIS software (Infors HT, Switzerland).
2.2.3. Cell lysis
Intracellular SCOMT was obtained via a combined lysis process.
Typically, 2mL of samples from fermentations were centrifuged at
4 ◦C and 16,000× g for 5min, resuspended in 500L of a standard
buffer (150mM NaCl, 10mM DTT, 50mM Tris, 5g/mL leupeptin
and 0.7g/mL pepstatin), transferred to lysis tubes and kept on ice.
The lysis process was then carried out as previously described [20].
The resulting supernatant, containing the solubilized SCOMT, was
used as sample for the enzyme activity and protein quantitation
assays.
2.2.4. Flow cytometry assays
In order to assess cellular viability during the fermentation runs,
samples were retrieved at speciﬁc times and treated for the ﬂow
cytometry assays, according to a previously developed protocol
[23]. The samples’ OD600 was measured and a dilution with PBS
buffer was prepared to obtain a ﬁnal OD600 of 0.2 (approximately
1×108 cells/mL and further diluted in PBS with 4mM NaEDTA to
a cell concentration of about 1×106 cells/mL). To this cell suspen-
sion, the appropriate volumes of PI and BOX were added in order
to attain ﬁnal concentrations of 10 and 2.5g/mL, respectively.
The samples were incubated for 15min at room temperature in
the dark, centrifuged for 5min at 5000 rpm and resuspended in
PBS prior to analysis in a CyAn ADP ﬂow cytometer (Beckman
Coulter Inc., California, United States). Acquisition and analysis
were performed with the Summit Software (Beckman Coulter
3 technology Reports 3 (2014) 34–41
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experiments were this strain’s growth rate and the time at which
to initiate the feeding process under these conditions. The growth
rates,  (h−1), obtained for the 1st, 2nd and 3rd formulations,
depicted previously, were 0.51, 0.49 and 0.55h−1, respectively,6 G.M. Espírito Santo et al. / Bio
nc., California, United States). The acquisition was based on light
catter and ﬂuorescence signals resulting from 25mW solid state
aser illumination at 488nm Fluorescence signals were collected
y FL1 (530/40nm, BOX) and FL4 (680/30nm, PI) bandpass ﬁlters.
ight scattering, BOX and PI ﬂuorescence measurements were
cquired logarithmically. Threshold was set on SSC to exclude
oise, other particles and debris. Cells were gated according to
heir light scatter parameters. Sample acquisition was operated
t ﬂow rate of no more than 300 events per second and a total of
000 cells were gated and analyzed for each sample.
.2.5. Analytical methods
.2.5.1. Glycerol. For glycerol determination, samples were
etrieved at speciﬁc times and centrifuged at 4 ◦C and 16,000× g
or 5min The resulting supernatant was then ﬁltered through
0.22m ﬁlter (Millipore) for subsequent HPLC analysis onto
n Agilent 1290 Inﬁnity LC HPLC system (Waldbronn, Germany)
oupled with a Refractive Index Detector (RID) (Agilent 1260
nﬁnity). Compound separation was achieved using a Hi-Plex H
on-exchange analytical column (Agilent, Santa Clara, CA, USA)
ith a 7.7×300mm and 8m pore size. The mobile phase
onsisted of a 5mM H2SO4 solution prepared with ultrapure
ater, ﬁltered through a 0.2m pore membrane and degassed for
5min before use. Flow rate was set to 0.6mL/min and column
emperature was set to 65 ◦C.
.2.5.2. Enzymatic activity. The enzyme activity was measured via
he quantity of metanephrine produced as a result of the reaction
etween recombinanthSCOMTand the substrate epinephrine,with
amples being processed as described elsewhere [24]. The resulting
etanephrine was measured via an HPLC system with coulochem-
cal detection as previously described [25], applying a total protein
oncentration of 150g/mL. Speciﬁcally, the injections were per-
ormed using a HPLC model Agilent 1260 system (Agilent, Santa
lara, CA, USA) equipped with an autosampler and quaternary
ump coupled to an ESA Coulochem III (Milford, MA, USA) coulo-
etric detector. Chromatographic separation was achieved on an
nalytical column Zorbax 300SB C18 reverse phase analytical col-
mn (250mm×4.6mm i.d. 5m) (Agilent, Santa Clara, CA, USA).
he mobile phase (0.1M sodium dihydrogen phosphate, 0.024M
itric acid monohydrate, 0.5mM OSA and 9% acetonitrile, v/v), pH
.9, was ﬁltered under vacuum (0.2m hydrophilic polypropylene
lter) and degassed in ultrasonic bath before use. Column efﬂuent
as monitored with an electrochemical detector by a coulomet-
ic mode, which was equipped with a 5011 high sensitivity dual
lectrode analytical cell (electrodes I and II) using a procedure of
xidation/reduction (analytical cell#1:+410mV;analytical cell#2:
350mV). The ﬂow rate applied was 1mL/min. Column tempera-
ure was optimized to 30 ◦C. The chromatograms were obtained by
onitoring the reduction signal of the working electrode II.
.2.6. Total protein
The protein determination was carried out using a Pierce BCA
roteinAssay kit (ThermoScientiﬁc, USA) on a 96well plate accord-
ng to manufacturer’s instructions, after which the absorbance at
70nm was measured and the values applied to a previously cal-
ulated calibration curve.
. Results
.1. Batch fermentationsTwo batches were performed at 30% dissolved oxygen to deter-
ine the typical growth curve under these conditions. Themedium
ompositionusedwas theonepreviouslydescribed in Section2.2.2,
ith a concentration of glycerol and tryptone of 30 and 20g/L,Fig. 1. Growth curves of E. coli in a batch process with 20, 30 and 40% dissolved
oxygen (n=2).
respectively. These fermentations showed that the stationaryphase
of growth is reachedafter approximately8hof fermentation.Under
these conditions the maximum OD attained is of about 28 (data not
shown).
Subsequently, the next step was to evaluate the effect of dis-
solved oxygen concentration on COMT production, testing three
set-points for dissolved oxygen concentrations (20, 30 and 40%)
and performing recombinant COMT induction. The three different
dissolved oxygen set-points (20%, 30% and 40%, Fig. 1) were tested
in duplicates and the results for each set-point were averaged. All
fermentations were stopped 4h after induction, according to the
experiments. For the activity assays, cell samples were retrieved
at the end of the fermentation. The results from Fig. 1 show that a
dissolved oxygen concentration of 20% gives better results than the
other two concentrations tested in terms of maximum OD reached.
The following step was the assessment of the most appropriate
carbon (glycerol) and nitrogen (tryptone) source concentrations in
the batch phase stage for the fed-batch process, in order to reduce
time, and also to increase cell density at the end of the batch phase.
It is extremely relevant to reduce batch and fed-batch times in
order to avoid, or at least minimize, nutrients/oxygen depletion.
To achieve this, the concentration of glycerol and tryptone were
varied, according with three formulations: 1st formulation (20g/L
glycerol and 20g/L tryptone), 2nd formulation (10g/L glycerol and
15g/L tryptone) and 3rd formulation (20g/L glycerol and 30g/L
tryptone) (growth curves were depicted in Fig. 2).
3.2. Growth rate and time of fed-batch initiation
The last parameters to be assessed before initiating fed-batchFig. 2. Growth curves of the assays corresponding to the three formulations (n=2).
1st formulation, 20g/L tryptone and glycerol; 2nd formulation, 10g/L glycerol and
15g/L tryptone; 3rd formulation, 20g/L glycerol, 30 g/L tryptone.
G.M. Espírito Santo et al. / Biotechnology Reports 3 (2014) 34–41 37
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pig. 3. Growth curves and glycerol concentration proﬁles of the assays for the cons
eeding for replicates A and B, respectively. II – 3 g glycerol/L/h, right and left arrows
ight and left arrows indicate the starting of the feeding for replicate A and B, respe
ndicating that these glycerol and tryptone concentrations allowed
imilar growth proﬁles. In theory, the fed-batch process should be
nitiated when the carbon source is completely depleted, to ensure
utrient limitation. Given this, it is relevant to know exactly when
he carbon source is completely depleted. So, glycerol concentra-
ion was measured every 2h for the three formulations mentioned
n the previous subsection. Results are consistent with the ini-
ial glycerol concentrations in each fermentation. The 1st and 3rd
ermentations were started at an initial glycerol concentration of
0 g/L, and the 2nd at 10g/L, and after 4h of fermentation, only
small amount of that initial glycerol was consumed (data not
hown).
.3. Fed-batch trials
Given all the previous assays, the fed-batch fermentations were
nitiated with a batch phase containing glycerol and tryptone at a
oncentrationof20g/Landadissolvedoxygenrateof20%. The feed-
ng proﬁles were initiated at 10.5h of batch fermentation. For the
reliminary fed-batch studies, two predetermined feeding proﬁles,
amely exponential and constant feeding were preferred. For each
eedingproﬁle, three feeding rateswereevaluated:1, 3 and6gglyc-
rol/L/h for constant feeds and 0.1, 0.2 and 0.3h−1 for exponential
eeds.
.3.1. Constant feeding proﬁles
To achieve the desired rates (1, 3 and 6g glycerol/L/h), several
eed mediums with different glycerol concentrations were pre-
ared. For these assays, the three feeding rates were tested as
uplicates (A and B), without induction, so that the growth pro-
les could be established (Fig. 3). In these fed-batch experiences,
lycerol was measured as mentioned in Section 2.2.4 until the end
f the feeding process. The growth curves for these proﬁles (Fig. 3)
how a maximum OD of about 50 which, as expected, is consid-
rably higher than those obtained in the batch experiments. For
he 1g/L/h constant feeding proﬁle, glycerol concentration was
ept close to zero until the end of the fed-batch process, mean-
ng that these cultures were able to consume all of the glycerol
rovided by the feeding solution. For the 3g/L/h constant feeding
roﬁle, glycerol concentration reached close to zero values onlyeding proﬁles. I – 1 g glycerol/L/h, left and right arrows indicate the starting of the
te the starting of the feeding for replicate A and B, respectively. III – 6 g glycerol/L/h,
y.
after about 10h of fed-batch, meaning that limiting concentrations
are not reached duringmost of the fed-batch process. However, the
maximum OD reached (52) was very similar to that of the 1g/L/h
feeding proﬁle. Finally, for the 6g/L/h feeding proﬁle, glycerol con-
centrations either increased throughout the experiment (replicate
A) or were kept constant at relatively low levels (replicate B). Since
glycerol concentrations during the fed-batch phase of the feeding
proﬁles evaluated were very different (from almost 0 g/L to as high
as 30g/L), cytometry assays were used to see if the feeding proﬁle
of 1 g/L/h was, in fact, the best choice among the three constant
feeding proﬁles tested.
In order to assess cell physiology during the fed-batch experi-
ments, ﬂow cytometry assays were carried out using a PI/BOX dual
staining. Dead cells will be stained with both BOX and PI, cells with
depolarized membrane will be stained only with BOX and viable
cells will not be stained. The results (not shown), indicate that as
fermentation time increases, the percentage of dead cells (stained
with PI and BOX) also increases. This effect is heightened at higher
feeding rates, possibly because of the higher glycerol concentra-
tions, which can hamper E. coli growth. In fact, at the end of the
fermentation, the average percentages of viable cells were 79.43,
65.84 and 75.61% for 1, 3 and 6g/L/h, respectively.
3.3.2. Exponential feeding proﬁles
The three chosen speciﬁc growth rates for exponential feeding
proﬁles were 0.1, 0.2 and 0.3h−1 with feed medium addition speed
being calculated according to an equation previously described
[14]. For this set of experiments, the three speciﬁc growth rates
were also performed in duplicates (A and B) without induction
(Fig. 4). Glycerol concentration and cellular viability assessments
were performed as described for the continuous feeding proﬁles.
The results showed that all three speciﬁc growth rates tested
yielded approximately the same maximum ODs (40–50), which
were also similar to those obtainedwith the constant feeds. In these
experiments, glycerol concentrations were generally high from the
start of the feeding, due to higher feeding speeds, indicating that
cells are not able to exhaust all the glycerol added to the culture
medium. Taking into account the results of both feeding proﬁles,
the selected feeding proﬁle for hSCOMT induction fermentation
was a constant feed of 1 g glycerol/L/h.
38 G.M. Espírito Santo et al. / Biotechnology Reports 3 (2014) 34–41
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or replicates A and B, respectively. II – 0.2h−1, left and right arrows indicate the sta
ndicate the starting of the feeding for replicates A and B, respectively.
.4. COMT production in fed-batch fermentations
As mentioned above, for the ﬁnal fermentations a constant feed
f 1 g glycerol/L/h was used, with a higher (50g/L) initial concen-
ration of tryptone in order to compensate the possible tryptone
imitation during the fed-batch phase. All other bioprocess param-
ters remainedunaltered. Firstly, a fermentationwithout induction
as performed, in order to determine the starting point of the
tationary phase with this new medium formulation, and con-
equently the start of the feeding (Fig. 5). As seen in Fig. 5, the
tationary phase was reached at about 8h into the fermentation,
nd that was the time chosen to initiate the feeding. However,
nd since there was no signiﬁcant increase in cell growth after this
oint, we decided to initiate the feeding 1h earlier (at 7h) in the
ubsequent experiment, with IPTG induction.
The induction was carried out 1h after starting of the feeding,
or 4h. In this fermentation, glycerol quantitation assays were car-
iedout asmentionedaboveandas expected, glycerol consumption
roﬁle was very similar to the previous assays carried out with this
eeding proﬁle, however in this case, glycerol concentration was
ow just from the beginning, and after 2h of feeding, the concen-
rations remained the same in both replicates (data not shown).
ytometry assays were carried out as explained above, and the
ig. 5. Growth curve for the ﬁnal fermentations, with (B) and without (A) IPTG
nduction (n=4). Arrow indicates the starting of the feeding for curve B.feeding proﬁles. I – 0.1h−1, right and left arrows indicate the starting of the feeding
of the feeding for replicates A and B, respectively. III – 0.3h−1, left and right arrows
results for these fermentations can be seen in Fig. 6 (only for the
ﬁrst replicate). As the results show, the percentage of viable cells at
the end of the fermentation are relatively high, between 84% and
almost 90%.
For the enzymatic assay, samples were taken every 2h after
induction (until 6 h of induction), and treated according to the
method described in Section 2.2.3. Speciﬁc activity results are
plotted in Fig. 5, and as we can observe an increment in activ-
ity is achieved during 6h after induction from 56nmol/h/mg to
442.34nmol/h/mg.
4. Discussion
In recent years, several attempts have been performed to obtain
a large quantity of active and pure hSCOMT. One of the most
effective ways of enhancing recombinant protein production is the
application of a fed-batch process, which highly increases cell den-
sity and, subsequently, proteinproduction. In thiswork, a fed-batch
bioprocess was developed for hSCOMT biosynthesis. Initially, sev-
eral batch fermentations were carried out, in order to establish and
optimize culture conditions, batch phase and bioreactor operation
for the fed-batch fermentations. After this stage, a series of fed-
batch fermentations with different feeding strategies were tested
in order to obtain the maximum biomass production.
4.1. Batch fermentations
Firstly, dissolved oxygen concentration in culture media was
studied, as it is one of the most difﬁcult variables to reproduce,
due to the combination of low oxygen solubility in water and the
requirement for pure oxygen supplementation when cell density
increases [26].As mentioned in Section 3, two batches were performed at
30% dissolved oxygen [19] to determine the typical growth curve
under these conditions. A maximum OD of 28 was obtained
in these assays, which was signiﬁcantly higher than the value
G.M. Espírito Santo et al. / Biotechno
Fig. 6. Cell samples taken at (A) 0h immediately after induction and (B) 6h after
induction, for the ﬁrst replicate. Cells were stained with PI/BOX, and up to three
main subpopulations of cells can be distinguished, corresponding to healthy polar-
ized cells (R5), not stained; depolarized cells (R6), stained with BOX; and cells with
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[14], and so three exponential feeding rates falling between theseermeabilized and depolarized cytoplasmatic membranes, (R4), stained with both
I and BOX.
reviously obtained [19] for fed-batch fermentations applying the
ame expression system, culture medium and dissolved oxygen
oncentration. In fact, just by applying the physical parameters
ptimized by [27] to a mini-bioreactor platform, maximum OD
alues reached were very promising.
Afterwards, three standard set points for dissolved oxygen con-
entration (20, 30 and 40%) were tested. Based on the maximum
D reached, these results showed that a batch at 20% oxygen gives
etter results than 30% and 40%. This may not correspond to the
xpected results as higher percentages of dissolved oxygen should
llow increased cell growth. However, the maintenance of the set
alue of dissolved oxygen is not possible throughout the whole
atch process using agitation and airﬂow cascade, indicating that
xygen supplementation might be needed for these fermentations.
ubsequently, twomore fermentation runsat20%dissolvedoxygen
ere performed, with samples for enzymatic activity assay being
ithdrawn every hour after induction, to verify whether there was
peak of activity during this 4h period. Therefore, we concluded
hat the best time for enzymatic activitywas, in fact, 4 h after induc-
ion, due to the fact that those times corresponded to the highest
alues of speciﬁc COMT activity (316.16 and 237.20nmol/h/mg
or each assay, respectively), what is in agreement with previous
esults [19,20].logy Reports 3 (2014) 34–41 39
The next step in this study was to test carbon and nitrogen
source concentrations in the batch phase. Regarding carbon source,
it is known that, when compared to glucose, glycerol could be a
better choice as it yields reduced acetate levels, low growth inhibi-
tion at high concentrations [13,14,19,28] and higher heterologous
protein expression levels in E. coli [19,29]. Lower concentrations
of glycerol (10–20g/L) were proven to be preferable for higher
hSCOMT speciﬁc activity results [19], and so, this was the con-
centration range chosen. Tryptone concentration variations were
kept around the 20g/L concentration present in the semi-deﬁned
medium, as it was previously optimized. From Fig. 2, it appears
that tryptone greatly inﬂuences cell growth, as the fermentation
with the higher tryptone concentration (3rd formulation) yielded
higher optical densities, whereas the fermentation with the lowest
tryptone concentration (2nd formulation) showed a decreased cell
density when compared with the other two formulations. Glycerol
does not seem to have such a great impact in cell growth at the
lower concentrations used in these experiments, since the two for-
mulations with different glycerol concentrations (1st and 2nd) led
to similargrowthproﬁlesandcell densities,whichmeets the results
previously obtained [19]. Since the main aim of these experiments
was to reduce the batch phase time, the selected formulation was
glycerol and tryptone at a concentration of 20g/L, the ﬁrst formu-
lation, due to the fact that nutrient exhaustion occurred at a lower
fermentation time (data not shown).
4.2. Fed-batch trials
To initiate the fed-batch trials, the growth rates for each glyc-
erol/tryptone combination had to be assessed, and we veriﬁed that
these were very similar and consistent with previously estimated
values [19] (about 0.50h−1 for a glycerol concentration of 10g/L).
It is important to determine the speciﬁc growth rates for each
formulation for the establishment of the feeding proﬁles, namely
exponential feeding proﬁles, as these are normally set to fall below
the maximum speciﬁc growth rate of the expression system, thus
minimizing acetate formation [14,30]. Results showed that, for the
selected formulation of 20g/L of glycerol and tryptone (1st formu-
lation), after 11h of fermentation almost all of the glycerol present
in the culture is consumed. This was the time selected to initiate
the feeding process. With all aspects determined, the feeding pro-
ﬁles were chosen, based on previously described feeding proﬁles
[19], on the typical growth rates for exponential feeding [14], and
on the maximum speciﬁc growth rates obtained for the batch fer-
mentations, since the growth rates selected for the feeding should
be lower than the maximum value obtained, in order to guarantee
complete glycerol consumption.
4.2.1. Constant feeding proﬁles
In a constant feeding strategy, a predetermined constant rate of
glycerol is fed to the reactor [14]. The results obtained for the fer-
mentations with constant feed proﬁles suggested that the amount
of glycerol fed to the bioreactor was signiﬁcantly higher than what
E. coli could consume.
From the three feeding proﬁles tested, the one that had a greater
reproducibility was 1g/L/h, and since all three of them achieved
similar maximum ODs (around 50), this seemed the best option to
perform a constant feeding proﬁle.
4.2.2. Exponential feeding proﬁles
Typically, exponential feeding allows cells to grow at pre-
determined speciﬁc growth rates, usually between 0.1 and 0.3h−1limits were chosen (0.1, 0.2 and 0.3h−1). The results for the
exponential feeding proﬁles suggested that cell growth was not
visibly hampered by the high glycerol concentrations observed in
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eeding stage, as these feeding proﬁles were able to achieve the
ame OD level of that obtained for the constant feeding proﬁles.
rom the three growth rates, the lower rate used (0.1h−1) seems
o be preferable, taking into account its reproducibility and the
bility of cells to consume the glycerol provided by the feed in the
arly stages of the fermentation.
Comparing these results to those obtained with constant feeds,
oth allowed the achievement of very similar maximum ODs
between 50 and 60, approximately), and because the feeding solu-
ions for the exponential feeds require much larger quantities of
lycerol, constant feeds seem preferable, considering the lower
osts associated in a further scale-up strategy.
Similarly to the results obtained for constant feeding experi-
ents, cellular viability results in exponential feeding showed that
henumber of dead cells increased throughout the fed-batchphase.
ince glycerol concentration did not seem to have a great inﬂu-
nce in cell growth and viability, it seems that other aspect may
e affecting cell growth in late stages of the fermentation. One of
he possibilities is the accumulation of toxic byproducts during the
rocess, that has been reported in fed-batch processes [14,22,27].
nother possible factor that might be inﬂuencing these results is
ryptone concentration, which might be hampering E. coli viability
s a limiting substrate.
.3. COMT production in fed-batch fermentations
Maximum OD reached in these fermentations was a little lower
about 40), which can be associated with IPTG induction, since this
nducer is known to be toxic and promote metabolic stress [13,17].
he comparison of cytometry results from the fermentations at
onstant feeding with the same feeding rate (1 g/L/h) showed over-
ll lower percentages of permeabilized and dead cells. This may
e possibly due to the higher concentration of tryptone present
n these fermentations, conﬁrming the above mentioned possible
ffect of low tryptone concentrations in cell viability. Another rea-
on for these seemingly better resultsmight be relatedwithprocess
uration. In these last assays, the whole process (batch and fed-
atch) only took 13h to develop, against the 17 and 22h of the
rocesses that used the same feeding rate. This shorter period was
robably due to the early implementation of the fed-batch tech-
ique (7h of batch fermentation, against 9 and 10 for the other
ssays).With lower fermentation times, possibly toxic by-products
re less likely to accumulate, or they do so at lower levels, and so
heir effect on cell viability is not so evident.
From Fig. 5, we can see that speciﬁc hSCOMT activity
nhances progressively after induction, with the highest value
442.34nmol/h/mg) being achieved 6h after induction, since the
romoter had more time to act.
. Conclusions
In this study, several fermentation conditions were tested to
ncrease SCOMT production in E. coli BL21 (DE3) strains, with the
im of developing a fed-batch strategy suitable for COMT produc-
ion and further scale-up. This study indicates that a fed-batch
rocess as a good option for recombinant human SCOMT pro-
uction in E. coli BL21 (DE3), and it was veriﬁed that a constant
eeding process is preferable to exponential feeding strategies. An
D600 of about 40 was achieved via a constant feeding proﬁle
f 1 g glycerol/L/h, with a maximum speciﬁc hSCOMT activity of
42.34nmol/h/mg. Finally, we veriﬁed that a high percentage of
iable cells was maintained at the end of the fermentation. The
ombined results of high optical densities reached in comparison
ith previous work with this protein in this expression system, the
igh speciﬁchSCOMTactivity andhighcell viability at theendof the
[logy Reports 3 (2014) 34–41
fermentation suggest that further optimization of this particular
expression system is a great option for human SCOMT production,
and a scale-up process could be extremely promising, giving even
better results in terms of cell growth and protein productivity.
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